Latest Safety News

Orica Limited reported a 6% increase in revenue to AUD 8.14 billion and a 23% rise in EBIT to AUD 992.2 million for FY2025, alongside record safety performance and significant strides in decarbonisation.

Spacetalk Ltd has secured an $877k R&D tax refund for FY2025, more than doubling last year’s amount, underscoring its strategic pivot to software and a 20% growth in recurring revenue.

The FDA's removal of the black box warning on hormone replacement therapies marks a pivotal shift for Mayne Pharma, potentially unlocking new market opportunities and reshaping women’s health treatment.

Actinogen Medical’s XanaMIA Phase 2b/3 trial for Alzheimer’s disease has received a positive safety recommendation from its independent Data Monitoring Committee, allowing the study to proceed unchanged. Investors now await the critical efficacy analysis scheduled for January 2026.

Radiopharm Theranostics has successfully enrolled the second cohort in its Phase 1 trial of 177Lu-RAD204, with the Data Safety Monitoring Committee greenlighting a dose increase to 90mCi for the third cohort. Early results show promising tumor targeting and safety in multiple advanced cancers.

Neurotech International has received a $4.73 million R&D tax incentive refund, reinforcing its clinical development efforts in paediatric neurological disorders. The funds will support ongoing trials and working capital needs.

Volt Group Limited is set to acquire 4D Delta, a Perth-based leader in digital asset inspection technology, in a $7.25 million deal that promises to diversify Volt’s offerings and boost recurring revenues in the mineral processing sector.

dorsaVi Limited has acquired a cutting-edge neuromorphic processing-in-memory technology portfolio, positioning itself at the forefront of next-generation wearable and robotics intelligence. This strategic move, coupled with leadership changes, signals a new era for the company’s adaptive biosensor and robotics platforms.

Life360 reported a robust Q3 2025 with 34% revenue growth and a significant jump in adjusted EBITDA, while advancing its advertising platform through the planned acquisition of Nativo and expanding into pet tracking services.

Life360 has announced its acquisition of advertising tech firm Nativo for $120 million, aiming to expand its advertising reach and enhance its platform with advanced technology. The deal is set to close in January 2026, promising to blend family insights with premium ad experiences.

Life360 has reported a record-breaking third quarter in 2025, with significant growth in users, revenue, and profitability, while announcing a strategic acquisition to expand its advertising capabilities.

Life360, Inc. reported robust Q3 2025 financial results driven by subscription and partnership revenue growth, alongside a leadership transition and strategic capital moves. The company also announced a major acquisition to bolster its advertising platform.